Cationic thermosensitive liposomes: A novel dual targeted heat-triggered drug delivery approach for endothelial and tumor cells

Nano Letters

Volumn 13, Issue 6, 2013, Pages 2324-2331

  Dicheva, Bilyana M ^a   Hagen, Timo L M Ten ^a   Li, Li ^a   Schipper, Debby ^a   Seynhaeve, Ann L B ^a   Rhoon, Gerard C Van ^a   Eggermont, Alexander M M ^a,d   Lindner, Lars H ^a,b,c   Koning, Gerben A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d Polyclinique de Rillieux   (France)

Author keywords

Cationic thermosensitive liposomes; drug delivery; hyperthermia; targeted nanomedicine; triggered release

Indexed keywords

HYPERTHERMIA; LIVE-CELL IMAGING; NANO-CARRIERS; OPTICAL IMAGING; SOLID TUMORS; THERMO SENSITIVE; THERMOSENSITIVE LIPOSOMES; TRIGGERED RELEASE;

CHEMOTHERAPY; DRUG DELIVERY; FLOW CYTOMETRY; LIPOSOMES; MEDICAL NANOTECHNOLOGY; TUMORS;

ENDOTHELIAL CELLS;

ANTINEOPLASTIC AGENT; CATION; LIPOSOME;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFECT; HEAT; TUMOR CELL CULTURE; VASCULAR ENDOTHELIUM; DRUG EFFECTS;

ANTINEOPLASTIC AGENTS; CATIONS; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; HOT TEMPERATURE; LIPOSOMES; TUMOR CELLS, CULTURED;

EID: 84879103048     PISSN: 15306984     EISSN: 15306992     Source Type: Journal    
DOI: 10.1021/nl3014154     Document Type: Article

References (35)

1. Gabizon, A.; Shmeeda, H; Barenholz, Y. Pharmacokinetics of pegylated liposomal doxorubicin-review of animal and human studies Clin. Pharmacokinet. 2003, 42 (5) 419-36
2. Gabizon, A. Selective tumor-localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes Cancer Res. 1992, 52 (4) 891-6
3. Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yauyoung, A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1991, 1066 (1) 29-36
4. Jain, R. K. Vascular and interstitial barriers to delivery of therapeutic agents in tumors Cancer Metastasis Rev. 1990, 3, 253-66
5. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Controlled Release 2000, 65 (1- 2) 271-84
6. Charrois, G. J. R.; Allen, T. M. Rate of biodistribution of STEALTH ((R)) liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity Biochim. Biophys. Acta 2003, 1609 (1) 102-8
7. Koning, G. A.; Krijger, G. C. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery Anti-cancer Agents Med. Chem. 2007, 7 (4) 425-40
8. O'Brien, M. E.; Wigler, N.; Inbar, M.; Rosso, R.; Grischke, E.; Santoro, A.; Catane, R.; Kieback, D. G.; Tomczak, P.; Ackland, S. P.; Orlandi, F; Mellars, L.; Alland, L.; Tendler, C. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer Ann. Oncol. 2004, 15 (3) 440-9
9. Judson, I.; Radford, J. A.; Harris, M.; Blay, J. Y.; Hoesel, Q.; Cesne, A.; van Oosterom, A. T.; Clemons, M. J.; Kamby, C.; Hermans, C.; Whittaker, J.; Donato di Paola, E.; Verweij, J.; Nielsen, S. Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group Eur. J. Cancer. 2001, 37 (7) 870-7
10. Campbell, R. B.; Fukumura, D.; Brown, E. B.; Mazzola, L. M.; Izumi, Y.; Jain, R. K.; Torchilin, V. P.; Munn, L. L. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors Cancer Res. 2002, 62 (23) 6831-6
11. Ran, S.; Downes, A.; Thorpe, P. E. Increased exposure of anionic phospholipids on the surface of tumor blood vessels Cancer Res. 2002, 62 (21) 6132-40
12. Vincent, S.; De Pace, D.; Finkelstein, S. Distribution of anionic sites on the capillary endothelium in an experimental brain tumor model Microcirc., Endothelium, Lymphatics 1988, 4 (1) 45-67
13. Ho, E. A.; Ramsay, E.; Ginj, M.; Anantha, M.; Bregman, I.; Sy, J.; Woo, J.; Osooly-Talesh, M.; Yapp, D. T.; Bally, M. B. Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties J. Pharm. Sci. 2010, 99 (6) 2839-53
14. Campbell, R. B.; Ying, B.; Kuesters, G. M.; Hemphill, R. Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics J. Pharm. Sci. 2009, 98 (2) 411-29
15. Yuan, F.; Dellian, M.; Fukumura, D.; Leunig, M.; Berk, D. A.; Torchilin, V. P.; Jain, R. K. Vascular-permeability in a human tumor xenograft-molecular- size dependence and cutoff size Cancer Res. 1995, 55 (17) 3752-6
16. Kong, G; Braun, R. D.; Dewhirst, M. W. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature Cancer Res. 2001, 61 (7) 3027-32
17. Dreher, M. R.; Liu, W.; Michelich, C. R.; Dewhirst, M. W.; Chilkoti, A. Thermal Cycling Enhances the Accumulation of a Temperature-Sensitive Biopolymer in Solid Tumors Cancer Res. 2007, 67 (9) 4418-24
18. Seynhaeve, A. L. B.; Hoving, S.; Schipper, D.; Vermeulen, C. E.; de Wiel- Ambagtsheer, G. A.; van Tiel, S. T.; Eggermont, A. M. M.; ten Hagen, T. L. M. Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response Cancer Res. 2007, 67 (19) 9455-62
19. Harrington, K. J.; Mohammadtaghi, S.; Uster, P. S.; Glass, D.; Peters, A. M.; Vile, R. G.; Stewart, J. S. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes Clin. Cancer Res. 2001, 7 (2) 243-54
20. Lindner, L. H.; Eichhorn, M. E.; Eibl, H.; Teichert, N.; Schmitt-Sody, M.; Issels, R. D.; Dellian, M. Novel temperature-sensitive liposomes with prolonged circulation time Clin. Cancer Res. 2004, 10 (6) 2168-78
21. Li, L.; ten Hagen, T. L. M.; Schipper, D.; Wijnberg, T. M.; van Rhoon, G. C.; Eggermont, A. M. M.; Lindner, L. H.; Koning, G. A. Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia J. Controlled Release 2010, 143 (2) 274-9
22. Lasic, D. D. Liposomes from physics to applications; Elsevier: Amsterdam, The Netherlands, 1993; pp 63-107.
23. Eibl, H.; Woolley, P. Electrostatic interactions at charged lipid membranes. Hydrogen bonds in lipid membrane surfaces Biophys. Chem. 1979, 10 (3-4) 261-71
24. Silvius, J. R. Anomalous mixing of zwitterionic and anionic phospholipids with double-chain cationic amphiphiles in lipid bilayers Biochim. Biophys. Acta 1991, 1070 (1) 51-9
25. Thurston, G.; McLean, J. W.; Rizen, M.; Baluk, P.; Haskell, A.; Murphy, T. J.; Hanahan, D.; McDonald, D. M. Cationic Liposomes Target Angiogenic Endothelial Cells in Tumors and Chronic Inflammation in Mice J. Clin. Invest. 1998, 101 (7) 1401-13
26. Krasnici, S.; Werner, A.; Eichhorn, M. E.; Schmitt-Sody, M.; Pahernik, S. A.; Sauer, B.; Schulze, B.; Teifel, M.; Michaelis, U.; Naujoks, K.; Dellian, M. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels Int. J. Cancer. 2003, 105 (4) 561-7
27. Kong, G.; Braun, R. D.; Dewhirst, M. W. Hyperthermia enables tumor specific nanoparticle delivery: effect of particle size Cancer Res. 2000, 60 (16) 4440-5
28. Strieth, S.; Eichhorn, M. E.; Sauer, B.; Schulze, B.; Teifel, M.; Michaelis, U.; Dellian, M. Neovascular targeting chemotherapy: Encaplulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature Int. J. Cancer 2004, 110 (1) 117-24
29. Dabbas, S.; Kaushik, R. R.; Dandamudi, S.; Kuesters, G. M.; Campbell, R. B. Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells Endothelium 2008, 15 (4) 189-201
30. Northfelt, D. W.; Dezube, B. J.; Thommes, J. A.; Miller, B. J.; Fischl, M. A.; Friedman-Kien, A.; Kaplan, L. D.; Du Mond, C.; Mamelok, R. D.; Henry, D. H. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial J. Clin. Oncol. 1998, 16 (7) 2445-51
31. Alberts, D. S.; Muggia, F. M.; Carmichael, J.; Winer, E. P.; Jahanzeb, M.; Venook, A. P.; Skubitz, K. M.; Rivera, E.; Sparano, J. A.; DiBella, N. J.; Stewart, S. J.; Kavanagh, J. J.; Gabizon, A. A. Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials Semin. Oncol. 2004, 31 (6 Suppl 13) 53-90
32. Hossann, M.; Wiggenhorn, M.; Schwerdt, A.; Wachholz, K.; Teichert, N.; Eibl, H.; Issels, R. D.; Lindner, L. H. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes Biochim. Biophys. Acta 2007, 1768 (10) 2491-9
33. Rouser, G.; Fkeischer, S.; Yamamoto, A. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots Lipids 1970, 5 (5) 494-6
34. Mabrey, S.; Sturtevant, J. M. Investigation of phase transitions of lipids and lipid mixtures by high sensitivity differential scanning calorimetry Proc. Natl. Acad. Sci. U.S.A. 1976, 73 (11) 3862-6
35. Papenfuss, H. D.; Gross, J. F.; Intaglietta, M.; Treese, F. A. A transparent access chamber for the rat dorsal skin fold Microvasc. Res. 1979, 18 (3) 311-8